To improve our understanding of the biology of breast cancer metastasis according to the organ site, we performed a phenotypic and molecular characterization of HER2 and 771 genes in 184 metastatic samples across 11 organs, including liver, lung, brain, and bone. This evidence concerns the gene ERBB2 and breast cancer.